trial
as of 2026-07-01Optimizing and Individualizing the Pharmacological Treatment of First-episode Schizophrenic Patients
NCTId NCT03451734
at a glance
Phase — · Completed
Enrollment 2,000 (actual)
Sponsored by Central South University
Primary completion 2021-06-30
Synthesized from structured facts only — each point cited above.
Design & status
Phase
—
Status
Completed
Enrollment
2,000 (actual)
Study type
Observational
Allocation
—
Model
—
Masking
—
Start
2018-01-23
Primary completion
2021-06-30
Eligibility
ALL · 17 Years · 65 Years
Interventions & indications
Sponsors
Central South UniversityLead Sponsor
Xiangya Hospital of Central South UniversityCollaborator
Shanghai Mental Health CenterCollaborator
West China HospitalCollaborator
First Affiliated Hospital of Zhejiang UniversityCollaborator
Air Force Military Medical University, ChinaCollaborator
Jiangsu Province Nanjing Brain HospitalCollaborator
Shanxi Medical UniversityCollaborator
Guangzhou Mental HospitalCollaborator
Capital Medical UniversityCollaborator
China Medical University, ChinaCollaborator
Hebei Medical UniversityCollaborator
Shenzhen Mental Health CenterCollaborator
Sun Yat-sen UniversityCollaborator
Wuhan Mental Health CentreCollaborator
Shanghai Jiao Tong University School of MedicineCollaborator
Sites
1 total
Changsha, China
Facts & assertions
4 sourced
Enrollment
2,000
Phase
NA
Primary Completion Date
2021-06-30
Status
COMPLETED
relationships
The graph out of here
lead_sponsor
company
collaborator
indication